Recombinant granulocyte colony-stimulating factor administered enterally to neonates is not absorbed

Darlene A. Calhoun, Akhil Maheshwari, Robert D. Christensen

Research output: Contribution to journalArticle

Abstract

Granulocyte colony-stimulating factor (G-CSF) is present in liquids swallowed by the fetus and neonate; specifically, amniotic fluid, colostrum, and human milk. The swallowed G-CSF has local effects on enteric cells, which express the G-CSF receptor. However, some portion of the G-CSF ingested by the fetus and neonate might be absorbed into the circulation and have systemic actions, such as stimulating neutrophil production. To assess this possibility we sought to determine if circulating G-CSF concentrations of neonates increase after enteral administration of recombinant human granulocyte colony-stimulating factor (rhG-CSF). This was a single-center, prospective, blinded, randomized, 2 x 2 crossover study, with each infant receiving 1 dose of rhG-CSF (100 μg/kg) and 1 dose of placebo. Plasma G-CSF concentrations were measured at 2 and 4 hours after administration of the test solution. No significant change in plasma G-CSF concentration was observed after the enteral administration of rhG-CSF. On this basis, we conclude that orally administered rhG-CSF is not absorbed in significant quantities, and we speculate that the G-CSF swallowed by the fetus and neonate has local but not systemic effects.

Original languageEnglish (US)
Pages (from-to)421-423
Number of pages3
JournalPediatrics
Volume112
Issue number2 I
DOIs
StatePublished - Aug 1 2003
Externally publishedYes

Fingerprint

Granulocyte Colony-Stimulating Factor
Newborn Infant
Fetus
Small Intestine
Granulocyte Colony-Stimulating Factor Receptors
Colostrum
Human Milk
Amniotic Fluid
Cross-Over Studies
Neutrophils
Placebos

Keywords

  • Cytokines
  • Development
  • Intestine
  • Neonates

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health

Cite this

Recombinant granulocyte colony-stimulating factor administered enterally to neonates is not absorbed. / Calhoun, Darlene A.; Maheshwari, Akhil; Christensen, Robert D.

In: Pediatrics, Vol. 112, No. 2 I, 01.08.2003, p. 421-423.

Research output: Contribution to journalArticle

Calhoun, Darlene A. ; Maheshwari, Akhil ; Christensen, Robert D. / Recombinant granulocyte colony-stimulating factor administered enterally to neonates is not absorbed. In: Pediatrics. 2003 ; Vol. 112, No. 2 I. pp. 421-423.
@article{0a70ca864c8046a8835a4bafe2862f8d,
title = "Recombinant granulocyte colony-stimulating factor administered enterally to neonates is not absorbed",
abstract = "Granulocyte colony-stimulating factor (G-CSF) is present in liquids swallowed by the fetus and neonate; specifically, amniotic fluid, colostrum, and human milk. The swallowed G-CSF has local effects on enteric cells, which express the G-CSF receptor. However, some portion of the G-CSF ingested by the fetus and neonate might be absorbed into the circulation and have systemic actions, such as stimulating neutrophil production. To assess this possibility we sought to determine if circulating G-CSF concentrations of neonates increase after enteral administration of recombinant human granulocyte colony-stimulating factor (rhG-CSF). This was a single-center, prospective, blinded, randomized, 2 x 2 crossover study, with each infant receiving 1 dose of rhG-CSF (100 μg/kg) and 1 dose of placebo. Plasma G-CSF concentrations were measured at 2 and 4 hours after administration of the test solution. No significant change in plasma G-CSF concentration was observed after the enteral administration of rhG-CSF. On this basis, we conclude that orally administered rhG-CSF is not absorbed in significant quantities, and we speculate that the G-CSF swallowed by the fetus and neonate has local but not systemic effects.",
keywords = "Cytokines, Development, Intestine, Neonates",
author = "Calhoun, {Darlene A.} and Akhil Maheshwari and Christensen, {Robert D.}",
year = "2003",
month = "8",
day = "1",
doi = "10.1542/peds.112.2.421",
language = "English (US)",
volume = "112",
pages = "421--423",
journal = "Pediatrics",
issn = "0031-4005",
publisher = "American Academy of Pediatrics",
number = "2 I",

}

TY - JOUR

T1 - Recombinant granulocyte colony-stimulating factor administered enterally to neonates is not absorbed

AU - Calhoun, Darlene A.

AU - Maheshwari, Akhil

AU - Christensen, Robert D.

PY - 2003/8/1

Y1 - 2003/8/1

N2 - Granulocyte colony-stimulating factor (G-CSF) is present in liquids swallowed by the fetus and neonate; specifically, amniotic fluid, colostrum, and human milk. The swallowed G-CSF has local effects on enteric cells, which express the G-CSF receptor. However, some portion of the G-CSF ingested by the fetus and neonate might be absorbed into the circulation and have systemic actions, such as stimulating neutrophil production. To assess this possibility we sought to determine if circulating G-CSF concentrations of neonates increase after enteral administration of recombinant human granulocyte colony-stimulating factor (rhG-CSF). This was a single-center, prospective, blinded, randomized, 2 x 2 crossover study, with each infant receiving 1 dose of rhG-CSF (100 μg/kg) and 1 dose of placebo. Plasma G-CSF concentrations were measured at 2 and 4 hours after administration of the test solution. No significant change in plasma G-CSF concentration was observed after the enteral administration of rhG-CSF. On this basis, we conclude that orally administered rhG-CSF is not absorbed in significant quantities, and we speculate that the G-CSF swallowed by the fetus and neonate has local but not systemic effects.

AB - Granulocyte colony-stimulating factor (G-CSF) is present in liquids swallowed by the fetus and neonate; specifically, amniotic fluid, colostrum, and human milk. The swallowed G-CSF has local effects on enteric cells, which express the G-CSF receptor. However, some portion of the G-CSF ingested by the fetus and neonate might be absorbed into the circulation and have systemic actions, such as stimulating neutrophil production. To assess this possibility we sought to determine if circulating G-CSF concentrations of neonates increase after enteral administration of recombinant human granulocyte colony-stimulating factor (rhG-CSF). This was a single-center, prospective, blinded, randomized, 2 x 2 crossover study, with each infant receiving 1 dose of rhG-CSF (100 μg/kg) and 1 dose of placebo. Plasma G-CSF concentrations were measured at 2 and 4 hours after administration of the test solution. No significant change in plasma G-CSF concentration was observed after the enteral administration of rhG-CSF. On this basis, we conclude that orally administered rhG-CSF is not absorbed in significant quantities, and we speculate that the G-CSF swallowed by the fetus and neonate has local but not systemic effects.

KW - Cytokines

KW - Development

KW - Intestine

KW - Neonates

UR - http://www.scopus.com/inward/record.url?scp=0041630595&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0041630595&partnerID=8YFLogxK

U2 - 10.1542/peds.112.2.421

DO - 10.1542/peds.112.2.421

M3 - Article

C2 - 12897302

AN - SCOPUS:0041630595

VL - 112

SP - 421

EP - 423

JO - Pediatrics

JF - Pediatrics

SN - 0031-4005

IS - 2 I

ER -